Prevotella Species

Your vagina is a living community, and the bacteria that dominate it shape everything from your fertility to your pregnancy outcomes to your cervical cancer risk. Measuring Prevotella tells you whether that community is tilting toward dysbiosis, a disrupted state where protective Lactobacillus bacteria lose ground to anaerobes.

This test quantifies how much Prevotella is in your vaginal swab, usually through molecular methods like qPCR or sequencing. When Prevotella climbs, it often means your vaginal ecosystem has shifted into a higher-diversity, less protective state that has been linked in research studies to bacterial vaginosis (BV), preterm birth, severe preeclampsia, infertility, and persistent HPV infections.

What Prevotella Actually Is

Prevotella is a genus of anaerobic bacteria (microbes that grow without oxygen) found across the human body, including the vagina, gut, mouth, and respiratory tract. In the vagina, low to moderate amounts can coexist with a Lactobacillus-dominated community, but high levels signal a community that has lost its protective lactic-acid producers.

Multiple Prevotella species are involved in BV, not just one. Prevotella bivia is the most studied, but a recent broad-range PNA probe study found that BV involvement extends across several Prevotella species. P. bivia contributes to sialidase activity (enzymes that break down protective mucus) and produces metabolic byproducts that feed other BV-associated bacteria, though Gardnerella vaginalis strains are the primary sialidase producers in BV biofilms. Biofilms in BV make antibiotics less effective, which is one reason BV so often comes back after treatment.

Bacterial Vaginosis

This is the connection with the strongest evidence. In a prospective study of women who developed incident BV, Prevotella bivia became significantly elevated about 4 days before BV onset, suggesting it plays an active role rather than being a passive bystander. Recent direct visualization of BV biofilms found Gardnerella species dominate the biofilm while P. bivia is present at lower counts, so its exact biofilm role is being reassessed. Quantitative PCR for Prevotella on vaginal swabs has been shown to diagnose BV with high sensitivity and specificity when load thresholds are used, and combining it with Atopobium vaginae further improves accuracy.

High Prevotella before treatment also predicts treatment failure. A study found that women with higher pretreatment Prevotella had significantly increased odds of BV recurrence after standard first-line antibiotics. Separately, a 2025 randomized trial in the New England Journal of Medicine showed that treating male sexual partners alongside the patient reduced BV recurrence from 63% to 35% at 12 weeks. If you have recurrent BV, knowing your Prevotella level helps explain why standard metronidazole may keep failing, though Prevotella testing is not yet used in routine practice to guide treatment decisions.

Preterm Birth and PPROM

The vaginal microbiome is one signal among many that has been linked to preterm birth. Studies show that women who deliver preterm tend to have lower Lactobacillus crispatus and higher Prevotella in early-to-mid pregnancy. In one study, a 20-genus prediction model that included Prevotella reached an area under the curve of 0.88, though a broader meta-analysis found that predictive accuracy across studies was generally low to modest (AUC 0.28 to 0.79) and that models trained on one dataset often performed poorly on another.

In women with preterm premature rupture of membranes (PPROM), Prevotella is one of the dominant taxa and persists even through latency antibiotics, marking a stuck dysbiotic state. A meta-analysis found the vaginal microbiome predicted earlier preterm birth (before 32 or 34 weeks) better than late preterm birth. Importantly, Prevotella presence alone does not always lead to preterm birth: one study found that Prevotella colonization alongside abundant Lactobacillus actually facilitated term birth, suggesting the balance between species matters more than Prevotella levels in isolation.

Severe Preeclampsia

A single study of 173 pregnant women in Taiwan found that severe preeclampsia was independently associated with higher vaginal Prevotella bivia abundance, alongside elevated TNF-alpha (a marker of inflammation in your blood). A combined model using Prevotella bivia, BMI, and TNF-alpha reached an area under the curve of about 0.80 for predicting severe preeclampsia, and BMI also influenced Prevotella bivia levels. Because this association was observed at the time of cesarean delivery in a single population, the evidence base remains preliminary.

Infertility and IVF Outcomes

In a study of women with and without infertility, those with infertility had different vaginal microbiome compositions and higher microbial diversity than fertile women, with Prevotella among the enriched genera. In IVF specifically, a pilot study found women whose embryo transfers failed had a higher proportion of vaginal samples positive for Prevotella bivia at transfer compared to those who achieved pregnancy.

Evidence on how IVF medications themselves affect the vaginal microbiome is mixed. A pilot study of 15 women found that controlled ovarian stimulation and progesterone supplementation increased Prevotella and decreased Lactobacillus, while a larger 2025 study of 67 women found that elevated estradiol during IVF actually shifted the community toward Lactobacillus dominance. There is no established clinical protocol for treating vaginal dysbiosis before embryo transfer, and the evidence remains based on small pilot studies.

HPV Persistence and Cervical Disease

Higher vaginal Prevotella has been observed in women with persistent high-risk HPV infection, cervical intraepithelial neoplasia (CIN, meaning precancerous cell changes), and cervical cancer. A 2025 systematic review and meta-analysis reported that Prevotella showed increased relative abundance with lesion severity, though the stepwise trend across HPV-negative, HPV-positive, CIN, and cancer groups did not reach statistical significance overall; the significant finding was higher Prevotella abundance in cervical cancer compared with HPV-negative women specifically.

A study of 920 women of childbearing age proposed that Prevotella acts as a hub of the cervicovaginal microbiota that influences persistent HR-HPV infection through host NF-kB and C-myc signaling pathways (cellular messengers that control inflammation and cell growth). This suggests Prevotella may help reshape the cervical environment in ways that allow high-risk HPV to persist.

Why One Reading Is Not Enough

Vaginal microbiome composition shifts substantially over time, and a single Prevotella measurement can mislead you. In a longitudinal study using daily vaginal sampling over two menstrual cycles, Prevotella bivia rose around menses even in women with otherwise normal flora. Between periods, the community was relatively stable, but the menstrual disruption was the single strongest perturbation observed.

For meaningful interpretation, get a baseline test, retest in 3 to 6 months if you are actively addressing dysbiosis (treating BV, preparing for IVF, planning pregnancy), and at least annually thereafter if you are tracking long-term reproductive health. Avoid sampling during menses or in the few days after intercourse, since both can transiently shift your reading.

When Results Can Be Misleading

• Menstrual cycle timing: Prevotella bivia rises around menses even in women with healthy flora. Test mid-cycle when possible.
• Recent antibiotics: Standard BV antibiotics like metronidazole and clindamycin sharply suppress Prevotella for days to weeks, masking your true baseline. Wait at least 4 weeks after finishing antibiotics before retesting.
• IVF medications: Fertility drugs can shift the vaginal community, though evidence is mixed: a pilot study found increased Prevotella with controlled ovarian stimulation and progesterone, while a larger study found elevated estradiol shifted the community toward Lactobacillus. If you are mid-cycle on fertility drugs, your reading reflects medication effects.
• Qualitative versus quantitative reporting: Prevotella is common in healthy women at low levels. A simple positive or negative result has poor specificity. Make sure your test reports a quantitative load or relative abundance, not just presence.

What to Do With an Out-of-Pattern Result

High Prevotella is rarely actionable in isolation. Pair it with companion tests that fill out the picture: a full vaginal microbiome panel including Gardnerella vaginalis, Atopobium vaginae, and Lactobacillus species; HPV testing if you are due for cervical screening; and inflammatory markers like hs-CRP if you have signs of systemic inflammation. If you are pregnant or planning pregnancy, share results with an obstetrician familiar with vaginal microbiome research, especially if you have a history of preterm birth or recurrent pregnancy loss.

For recurrent BV with high Prevotella, the standard pathway is to retreat with extended or alternative antibiotic protocols, address partner factors when applicable (with growing RCT support for concurrent male partner treatment), and consider adjunctive vaginal probiotics. For pre-IVF testing, an unfavorable result may prompt your fertility specialist to consider dysbiosis, though there is no established protocol. For HPV-positive women, persistent high Prevotella may justify more frequent cervical surveillance.